1. Home
  2. ZVIA vs LPCN Comparison

ZVIA vs LPCN Comparison

Compare ZVIA & LPCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

HOLD

Current Price

$1.25

Market Cap

96.4M

ML Signal

HOLD

Logo Lipocine Inc.

LPCN

Lipocine Inc.

HOLD

Current Price

$7.30

Market Cap

61.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVIA
LPCN
Founded
2007
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.4M
61.8M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
ZVIA
LPCN
Price
$1.25
$7.30
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$4.93
$15.00
AVG Volume (30 Days)
635.5K
129.0K
Earning Date
05-06-2026
03-10-2026
Dividend Yield
N/A
N/A
EPS Growth
55.88
46.18
EPS
N/A
N/A
Revenue
$161,259,000.00
$1,976,677.00
Revenue This Year
$8.33
N/A
Revenue Next Year
$6.84
$74.43
P/E Ratio
N/A
N/A
Revenue Growth
4.01
N/A
52 Week Low
$1.11
$2.52
52 Week High
$3.66
$12.37

Technical Indicators

Market Signals
Indicator
ZVIA
LPCN
Relative Strength Index (RSI) 35.14 42.79
Support Level $1.11 $2.87
Resistance Level $2.74 $8.35
Average True Range (ATR) 0.06 0.68
MACD 0.00 -0.13
Stochastic Oscillator 34.92 22.79

Price Performance

Historical Comparison
ZVIA
LPCN

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

Share on Social Networks: